Cheat sheet
FPGEE Cheat Sheet
Basic Biomedical Sciences
- 12% of exam
- Renal CV Physiology Biochemistry Enzyme Kinetics Immunology Microbiology
Pharmaceutical Sciences
- 31% of exam
- Pharmacokinetics CYP450 Drug Name Stems Calculations Compounding
Social/Behavioral/Admin Sciences
- 20% of exam
- Controlled Substances Pharmacy Law Biostatistics Pharmacoeconomics
Pharmacy Practice & Clinical Sciences
- 37% of exam
- Diabetes Hypertension Infectious Disease Pulmonology Psychiatry Oncology
Quick Facts
- Exam FPGEE
- Questions 200
- Time 4.5 hours
- Pass Score 75 (scaled)
- Format Computer, fixed-form
- Level Foreign pharmacy graduate
- Administrator NABP / Pearson VUE
- Attempts 5 lifetime maximum
Antibody Response Order BI
- IgM first responder, then IgG for memory
- IgM: acute phase IgG: long-term memory IgA: mucosal defense IgE: allergy/parasites
Competitive vs Noncompetitive Inhibition BI
Competitive
- Raises Km value
- Same Vmax retained
- Overcome by more substrate
Noncompetitive
- Km stays same
- Lowers Vmax value
- Substrate cannot reverse it
- Km shifts vs Vmax shifts
Renal & CV Physiology BI
- PCT Reabsorbs glucose, amino acids
- Loop of Henle Builds concentration gradient
- ADH Signals water reabsorption
- RAAS Regulates BP and volume
- Normal GFR ~120 mL/min
- Frank-Starling Preload raises stroke volume
IgE vs IgG Antibodies BI
IgE
- Drives allergic reactions
- Fights parasitic infection
IgG
- Crosses the placenta
- Provides lasting immunity
- Allergy driver vs lasting immunity
Biochemistry & Enzyme Kinetics BI
- Glycolysis Glucose to pyruvate
- Krebs cycle Mitochondrial ATP production
- Km Lower means higher affinity
- Vmax Maximum reaction rate
- Competitive inhibitor Raises Km, same Vmax
- Noncompetitive inhibitor Lowers Vmax, same Km
Immunology & Microbiology BI
- IgG Crosses the placenta
- IgA Found in mucosal secretions
- IgE Allergy and parasite defense
- IgM First antibody responder
- Gram-positive Thick peptidoglycan wall
- Gram-negative LPS outer membrane
Common Drug Suffixes PH
- olol beta, -pril ACE, -sartan ARB
- olol: beta blocker -pril: ACE inhibitor -sartan: ARB -statin: cholesterol
Zero-Order vs First-Order Kinetics PH
Zero-order
- Constant amount eliminated
- Enzymes get saturated
- Phenytoin, ethanol, aspirin examples
First-order
- Constant fraction eliminated
- Most drugs follow
- Concentration-proportional elimination rate
- Amount vs fraction removed
Pharmacokinetic Parameter Selection PH
- Need distribution volume estimate → Calculate Vd
- Need elimination rate estimate → Calculate half-life
- Renal dose adjustment needed → Cockcroft-Gault CrCl
- Narrow index drug dosed → Therapeutic drug monitoring
- High-risk vancomycin dosing → AUC/MIC monitoring
Pharmacokinetic Formulas PH
- Vd Dose divided by C0
- Half-life 0.693 x Vd over CL
- Cockcroft-Gault Estimates creatinine clearance
- Steady state Reached in 4-5 half-lives
- Loading dose Vd x target concentration
- Maintenance dose CL x Css x tau
- Zero-order kinetics Constant amount eliminated
- First-order kinetics Constant fraction eliminated
Steady State Rule PH
- Steady state reached after 4-5 half-lives
- 4 half-lives: ~94% 5 half-lives: ~97% Same for loading/elimination
Compounding Standard Selection PH
- Sterile IV preparation needed → Follow USP <797>
- Nonsterile capsule or cream → Follow USP <795>
- Hazardous chemo drug handled → Follow USP <800>
- Checking product expiration date → Confirm beyond-use date
CYP450 & Drug Interactions PH
- CYP3A4 Metabolizes most drugs
- CYP2D6 Activates codeine, tramadol
- Grapefruit juice Inhibits CYP3A4
- Rifampin Potent CYP inducer
- Narrow index drugs Warfarin, digoxin, lithium
USAN Drug Name Stems PH
- olol Beta blocker
- pril ACE inhibitor
- sartan ARB
- statin HMG-CoA reductase inhibitor
- dipine Dihydropyridine CCB
- azole Antifungal or PPI
- floxacin Fluoroquinolone antibiotic
- cillin Penicillin antibiotic
- gliflozin SGLT2 inhibitor
Pharmaceutical Calculations PH
- Alligation Mixes two strengths
- % w/v Grams per 100 mL
- Osmolarity mOsm solute per liter
- Isotonic solution Equivalent to 0.9% NaCl
- Aliquot method Dilutes very small doses
Compounding & Dosage Forms PH
- USP <795> Nonsterile compounding standard
- USP <797> Sterile compounding standard
- USP <800> Hazardous drug handling
- Enteric coating Delays release past stomach
- Beyond-use date Compounded product expiration
Schedule II vs Schedule III-V Refills SO
Schedule II
- No refills allowed
- New Rx required
Schedule III-V
- Up to 5 refills
- Within 6 months
- Refill rules differ by schedule
Controlled Substance Rx Rules SO
- Schedule II refill requested → Not allowed, new Rx
- Emergency Schedule II supply → Oral order permitted
- Schedule III-V refill requested → Up to 5 refills
- Suspected prescription diversion → Report per state law
Controlled Substance Schedules SO
- Schedule I No accepted medical use
- Schedule II High abuse, accepted use
- Schedule III Moderate abuse potential
- Schedule IV Low abuse potential
- Schedule V Lowest abuse potential
- CII prescriptions No refills allowed
Pharmacy Law Essentials SO
- HIPAA Protects patient privacy
- OBRA '90 Requires patient counseling
- PPPA Child-resistant packaging law
- DSCSA Tracks drug supply chain
- REMS Manages high-risk drug safety
Biostatistics & Pharmacoeconomics SO
- p-value <0.05 Statistically significant result
- 95% CI Range of confidence
- NNT Patients treated per benefit
- Cost-effectiveness analysis Cost per clinical outcome
- Cost-utility analysis Cost per QALY
- Type I error False positive finding
Blood Pressure Stages CL
- 120 elevated, 130 stage one, 140 stage two
- <120/80: normal 120-129: elevated 130-139: stage 1 ≥140/90: stage 2
Trough Monitoring vs AUC/MIC CL
Trough-only (old)
- 15-20 mcg/mL target
- Higher nephrotoxicity risk
AUC/MIC (current)
- 400-600 target range
- 2020 ASHP/IDSA standard
- AUC guides vancomycin dosing now
Drug Class Selection Logic CL
- T2DM first-line therapy needed → Metformin
- ASCVD risk reduction needed → High-intensity statin
- HFrEF maintenance therapy → ACEI/ARNI plus beta-blocker
- AFib stroke prevention needed → DOAC preferred agent
- MRSA skin infection → Vancomycin or linezolid
- H. pylori infection confirmed → Quadruple therapy regimen
Diabetes & Endocrine (ADA) CL
- A1C diagnosis ≥6.5% confirms diabetes
- Prediabetes A1C 5.7% to 6.4%
- Fasting glucose diagnosis ≥126 mg/dL
- Metformin First-line for T2DM
- GLP-1/SGLT2 CV and renal benefit
ACE Inhibitor vs ARB CL
ACE inhibitor
- Blocks ACE enzyme
- Often causes dry cough
ARB
- Blocks receptor directly
- Rarely causes cough
- Cough favors switching to ARB
Hypertension & Cardiology CL
- Normal BP Below 120/80
- Stage 1 HTN 130-139/80-89 mmHg
- Stage 2 HTN 140/90 mmHg or higher
- Warfarin INR target 2 to 3
- Digoxin range 0.5 to 2 ng/mL
- DOACs No routine INR monitoring
Infectious Disease & Immunizations CL
- Vancomycin target AUC/MIC 400-600
- CURB-65 Pneumonia severity score
- MRSA therapy Vancomycin or linezolid
- C. diff first-line Vancomycin or fidaxomicin
- Live vaccines Avoid in immunosuppressed
- Penicillin allergy Use caution with cephalosporins
Pulmonology, Psychiatry & Oncology CL
- GOLD mild COPD FEV1 ≥80% predicted
- GOLD severe COPD FEV1 30-49% predicted
- SSRI First-line for depression
- Lithium range 0.6 to 1.2 mEq/L
- Serotonin syndrome Hyperthermia, clonus, agitation
- Myelosuppression Common chemo dose-limiting toxicity
Common Traps
Schedule II vs III Refills
- CII = no refills ≠ CIII-V = up to 5
Trough vs AUC Vancomycin
- Trough alone is outdated ≠ AUC/MIC is current standard
Km vs Vmax Inhibition
- Competitive raises Km ≠ Noncompetitive lowers Vmax
Zero-Order vs First-Order
- Zero-order = constant amount ≠ First-order = constant fraction
IgE vs IgG Function
- IgE drives allergy ≠ IgG gives lasting immunity
Elevated vs Stage 1 BP
- Elevated = under 130/80 ≠ Stage 1 = 130-139/80-89
ACEI Cough vs ARB
- ACEI often causes cough ≠ ARB rarely causes cough
Last Minute
- 1. Weights: 12/31/20/37 percent
- 2. 200 questions, 4.5 hours total
- 3. Scaled passing score is 75
- 4. Clinical Sciences is largest domain
- 5. CII drugs are never refillable
- 6. Vancomycin: AUC/MIC 400-600 target
- 7. A1C of 6.5%+ confirms diabetes
- 8. Stage 2 HTN: ≥140/90
- 9. Km up means competitive inhibition
- 10. First-order: constant fraction eliminated
- 11. FPGEE offered once per year
- 12. Maximum 5 lifetime FPGEE attempts
NABP FPGEE Foreign Pharmacy Graduate Examination
- Practice Questions 200 questions Study Guide 42 topics Cheat Sheet 90 facts Flashcards 50 cards Videos 1 video Blogs 1 blog Free CE Podcast